Title: A425
Official Title: 
Number of Sections: 1
Source: versions - Introduced Version
Media Type: text/html

================================================================================

Section 1:
A425 ASSEMBLY, No. 425 STATE OF NEW JERSEY 221st LEGISLATURE PRE-FILED FOR INTRODUCTION IN THE 2024 SESSION Sponsored by: Assemblyman  ROBERT AUTH District 39 (Bergen and Passaic) Assemblyman  JOHN V. AZZARITI JR., M.D. District 39 (Bergen) Co-Sponsored by: Assemblywoman Flynn SYNOPSIS Requires long-term care facilities to stock and provide COVID-19 antiviral treatments to residents. CURRENT VERSION OF TEXT Introduced Pending Technical Review by Legislative Counsel. An Act concerning COVID-19 antiviral treatments in long-term care facilities and supplementing Title 26 of the Revised Statutes. Be It Enacted by the Senate and General Assembly of the State of New Jersey: 1.  a.  Each long-term care facility shall maintain an adequate supply of antiviral treatment for COVID-19 on site for its residents.  The long-term care facility shall provide any resident, who has tested positive for COVID-19 and is symptomatic, antiviral treatment for COVID-19. b.  As used in this section, "long-term care facility" means a nursing home or assisted living residence licensed pursuant to P.L.1971, 41 c.136 (C.26:2H-1 et seq.). 2.  This act shall take effect immediately. STATEMENT This bill requires long-term care facilities to stock and provide COVID-19 antiviral treatments to their residents. Under this bill, a long-term care facility will maintain an adequate supply of antiviral treatment for COVID-19 on site for its residents.  The long-term care facility will provide any resident, who has tested positive for COVID-19 and is symptomatic, antiviral treatment for COVID-19.  The bill defines "long-term care facility" to mean a nursing home or assisted living residence licensed pursuant to P.L.1971, 41 c.136 (C.26:2H-1 et seq.).


================================================================================

Raw Text:
A425 ASSEMBLY, No. 425 STATE OF NEW JERSEY 221st LEGISLATURE PRE-FILED FOR INTRODUCTION IN THE 2024 SESSION Sponsored by: Assemblyman  ROBERT AUTH District 39 (Bergen and Passaic) Assemblyman  JOHN V. AZZARITI JR., M.D. District 39 (Bergen) Co-Sponsored by: Assemblywoman Flynn SYNOPSIS Requires long-term care facilities to stock and provide COVID-19 antiviral treatments to residents. CURRENT VERSION OF TEXT Introduced Pending Technical Review by Legislative Counsel. An Act concerning COVID-19 antiviral treatments in long-term care facilities and supplementing Title 26 of the Revised Statutes. Be It Enacted by the Senate and General Assembly of the State of New Jersey: 1.  a.  Each long-term care facility shall maintain an adequate supply of antiviral treatment for COVID-19 on site for its residents.  The long-term care facility shall provide any resident, who has tested positive for COVID-19 and is symptomatic, antiviral treatment for COVID-19. b.  As used in this section, "long-term care facility" means a nursing home or assisted living residence licensed pursuant to P.L.1971, 41 c.136 (C.26:2H-1 et seq.). 2.  This act shall take effect immediately. STATEMENT This bill requires long-term care facilities to stock and provide COVID-19 antiviral treatments to their residents. Under this bill, a long-term care facility will maintain an adequate supply of antiviral treatment for COVID-19 on site for its residents.  The long-term care facility will provide any resident, who has tested positive for COVID-19 and is symptomatic, antiviral treatment for COVID-19.  The bill defines "long-term care facility" to mean a nursing home or assisted living residence licensed pursuant to P.L.1971, 41 c.136 (C.26:2H-1 et seq.).